Goswami et al. [48] described that the TWIST1 expression level in CTCL was associated with the progression of the disease level from the indolent mycosis fungoides stage to the aggressive Sezary syndrome stage. This evidence concerns the gene TWIST1 and primary cutaneous T-cell non-Hodgkin lymphoma.